Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium (Q42905241)
Jump to navigation
Jump to search
scientific article published on July 1, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium |
scientific article published on July 1, 2010 |
Statements
1 reference
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium (English)
1 reference
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium (English)
Laurie Elit
1 reference
Lisa Wang
1 reference
Katrina Macalpine
1 reference
Stephen A. Welch
Hal W. Hirte
Russel J. Schilder
1 July 2010
1 reference
1 reference
20
1 reference
5
1 reference
787-793
1 reference
1 reference
Identifiers
1 reference
1 reference